ACIP Meets to Discuss Janssen COVID-19 Vaccine; Pause on Use Still in Place
Based on the available information, the panel was unable to decide on next steps for the Janssen COVID-19 vaccine.
Thromboembolic Disorders
Rare Thrombosis, Thrombocytopenia Seen After AstraZeneca COVID-19 Vaccine
Reports document 16 reactions in young European patients following first dose of ChAdOx1 nCoV-19 vaccine
CDC, FDA Recommend Pausing Use of Janssen COVID-19 Vaccine After Reports of Rare Blood Clot
In all 6 cases, symptoms developed 6 to 13 days after vaccination.
Do Successive Transfers of an Emergency Patient Amount to an EMTALA Violation?
This month we look at a case involving the Emergency Medical Treatment and Labor Act, commonly referred to as EMTALA. EMTALA was enacted by Congress in 1986 as part of the Consolidated Omnibus Budget Reconciliation Act (COBRA) of 1985. The act was designed to prevent hospitals from ‘patient dumping’; transferring uninsured or Medicaid patients to…
Medtronic Stent Graft System Recalled Due to Fractures, Endoleaks
The recall was initiated due to reports of stent fractures and endoleaks.
FDA-Approved VEGFR Tyrosine Kinase Inhibitors Ranked by Cardiotoxic Potential
Lenvatinib was associated with the most significant probability of producing all grades of cardiovascular injury and hypertension.
Renal Dysfunction, Lower Body Weight May Up Bleeding Risk in Afib Patients on DOACs
The authors reported that 25 of the total 233 patients included in the study experienced a bleeding event.
ASA: Adding Icosapent Ethyl to Statin Further Cuts Stroke Risk
Event rates for time to first fatal or nonfatal stroke significantly reduced for IPE versus placebo
Antidepressants Not Tied to Increased Intracerebral Hemorrhage Risk
Selective serotonin reuptake inhibitors are not associated with higher risk for intracerebral hemorrhage
Vazalore, a Liquid-Filled Capsule Formulation of Aspirin, Gets FDA Approval
Vazalore is indicated as a pain reliever, fever reducer, and for aspirin therapy indications.
